Literature DB >> 2344577

Lead exposure among mothers and their newborns in Toronto.

G Koren1, N Chang, R Gonen, J Klein, L Weiner, H Demshar, S Pizzolato, I Radde, J Shime.   

Abstract

Recent studies have suggested that a fetal blood lead level of 0.48 mumol/L (much lower than 1.21 mumol/L, which is the level previously believed to be toxic to the developing brain) may impair brain development permanently. We measured the maternal and umbilical cord blood levels of lead and free erythrocyte protoporphyrin (FEP) among 95 consecutive mother-infant pairs to determine whether neonates in Toronto are in the high-risk group. There was a significant correlation between the maternal and the cord blood lead levels (r = 0.59, p less than 0.0001). Most (99%) of the infants had cord blood lead levels below 0.34 mumol/L; in 11 cases the levels were below the detection limit of 0.01 mumol/L. The cord blood FEP levels were higher than the maternal levels. The US Centers for Disease Control, Atlanta, currently finds acceptable a blood FEP level of 0.62 mumol/L among children up to 10 years of age; however, this is not applicable to newborns since their higher FEP levels apparently reflect immature heme synthesis and increased erythrocyte volume rather than lead poisoning. Our data suggest that living in Toronto does not impose increased teratogenic risk from intrauterine exposure to lead; however, residents in high-risk areas should be followed up.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2344577      PMCID: PMC1452610     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  6 in total

1.  Microsampling technique and determination of blood lead by Zeeman atomic absorption spectrophotometry.

Authors:  S T Wang; S Pizzolato; F Peter
Journal:  Sci Total Environ       Date:  1988-04       Impact factor: 7.963

2.  Motherisk--a new approach to antenatal counselling of drug/chemical exposure.

Authors:  G Koren; Y Feldman; N Shear
Journal:  Vet Hum Toxicol       Date:  1986-12

Review 3.  The neurotoxicology of lead.

Authors:  M R Moore; M J McIntosh; I W Bushnell
Journal:  Neurotoxicology       Date:  1986       Impact factor: 4.294

4.  Perception of teratogenic risk by pregnant women exposed to drugs and chemicals during the first trimester.

Authors:  G Koren; M Bologa; D Long; Y Feldman; N H Shear
Journal:  Am J Obstet Gynecol       Date:  1989-05       Impact factor: 8.661

5.  Longitudinal analyses of prenatal and postnatal lead exposure and early cognitive development.

Authors:  D Bellinger; A Leviton; C Waternaux; H Needleman; M Rabinowitz
Journal:  N Engl J Med       Date:  1987-04-23       Impact factor: 91.245

6.  Port Pirie Cohort Study: environmental exposure to lead and children's abilities at the age of four years.

Authors:  A J McMichael; P A Baghurst; N R Wigg; G V Vimpani; E F Robertson; R J Roberts
Journal:  N Engl J Med       Date:  1988-08-25       Impact factor: 91.245

  6 in total
  6 in total

Review 1.  Lead exposure during breastfeeding.

Authors:  Jacquelyn Choi; Toshihiro Tanaka; Gideon Koren; Shinya Ito
Journal:  Can Fam Physician       Date:  2008-04       Impact factor: 3.275

2.  Lead risk during pregnancy.

Authors: 
Journal:  Can Fam Physician       Date:  1996-03       Impact factor: 3.275

3.  Is lead a concern in Canadian autistic children?

Authors:  Brenda Clark; Ben Vandermeer; Antonio Simonetti; Irena Buka
Journal:  Paediatr Child Health       Date:  2010-01       Impact factor: 2.253

4.  Lead levels in Canadian children: Do we have to review the standard?

Authors:  Stephen N Tsekrekos; Irena Buka
Journal:  Paediatr Child Health       Date:  2005-04       Impact factor: 2.253

5.  Reproductive and developmental hazards and employment policies.

Authors:  J D Johnston; G G Jamieson; S Wright
Journal:  Br J Ind Med       Date:  1992-02

6.  Pediatric reference ranges for zinc protoporphyrin.

Authors:  Offie Porat Soldin; Maureen Miller; Steven J Soldin
Journal:  Clin Biochem       Date:  2003-02       Impact factor: 3.281

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.